Veloxis Pharmaceuticals A/S Establishes a New Warrant Programme

Published: Jan 24, 2013

Today, the Board of Directors of Veloxis Pharmaceuticals A/S (the "Company") has decided to establish a new warrant programme for members of management of the Company. Thus, the Board of Directors of the Company has today partly exercised its authorisation pursuant to Section 5A of the Articles of Association.

Back to news